
Aflibercept, an investigational angiogenesis inhibitor, improved overall survival as a second-line treatment for patients with mCRC

Aflibercept, an investigational angiogenesis inhibitor, improved overall survival as a second-line treatment for patients with mCRC

Abiraterone acetate gains FDA approval by demonstrating the ability to extend survival in patients with metastatic castrate-resistant prostate cancer

A class of drugs that has shown encouraging results in breast and ovarian cancers with BRCA gene mutations may also benefit patients who have colorectal cancers

The American Society of Hematology (ASH) is sounding a fresh alarm about ongoing supply problems with oncology drugs

Nektar Therapeutics announced that its oncology drug candidate, NKTR-102, has been granted orphan drug status

Most of the current research on yoga in people living with cancer is Hatha yoga, this entry addresses other principal yoga practices

The release of the data was a requirement of the national health care reform act.

The difficulties with choosing a prostate cancer treatment were highlighted once again by a recent study published in the Journal of Urology

Exposure to air pollution at certain times in a woman's life can leave her more susceptible to premenopausal breast cancer

Cervical cancer affects about 470,000 women each year and now the disease has a new tool to combat its spread

Shirnett Williamson, MD, PhD and Derrick Grant, PhD constitute a living definition of translational oncology

Yoga is the Sanskrit term for Yoke or Union. There are 8 limbs of yoga practice.

Siddhartha Mukherjee's acclaimed book, The Emperor of All Maladies: A Biography of Cancer, has won the 2011 Pulitzer Prize in the general nonfiction category

The FDA has approved a novel device that uses electric fields to treat aggressive brain tumors

Yoga is a lifestyle that promotes health. Health, through yoga practice, encompasses physical, mental and spiritual well-being.

The chorus of support is growing among oncology experts for routine genetic testing of tumors from patients with advanced non-small cell lung cancer

I have just returned from the 21st Interdisciplinary Conference of the National Consortium of Breast Centers

The FDA reported today that TNF blockers may be responsible for an increased incidence of HSTCL in adolescents and young adults

Pfizer's sunitinib provides a favorable benefit-risk profile in patients with unresectable pancreatic neuroendocrine tumors (pNETs)

Welcome to our blog, Yoga for Cancer Care

After much anticipation the Oncologic Drugs Advisory Committee has returned a verdict on Novartis' everolimus (Afinitor)

The march toward personalized cancer care may have taken a step forward with the discovery of a potential biomarker

A new prostate cancer screening test yielded more detailed and specific results for prostate-specific antigen

The FDA has approved vandetanib for the treatment of unresectable, late-stage, metastatic medullary thyroid cancer

Lung cancer in nonsmokers may soon have an adjunctive blood test for revealing common biomarkers

A team of researchers explored the use of drugs in terms of breast cancer prevention strategies

Help kidney cancer patients by being aware of available resources and support services

Evidence that surveillance by mammogram in breast cancer survivors has been lacking until now

Iniparib remains an intriguing therapeutic possibility despite failing to meet its phase III primary endpoints

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining